InsidersTradesSigma
바이오포트 Stock: price and directors' dealings · South Korea · DART (FSS)
Follow the 바이오포트 stock price and the full directors' dealings record of the company, a listed issuer based in South Korea. Shares are listed on KR KR, under the authority of DART (FSS). Operating in the Health Care sector, 바이오포트 has logged 5 reports. The latest transaction was filed on 16 July 2026 (Purchase). Among the most active insiders: 김성구. Every trade is openly available.
5
Insider Decl.
n/a
Thresholds
n/a
5 ops.
Buy Volume
n/a
n/a
Sell Volume
5Σ signal
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.
Last declaration on 16 July 2026
Declarations5 total
5 of 5 declarations
About 바이오포트
Bioport is a healthcare and pharmaceutical company listed on the XKRX market. It specializes in the development of biopharmaceutical products.